Business Context and Reporting Period
This Form 8-K reports on the results of the 2023 Annual Meeting of Stockholders held by LeMaitre Vascular, Inc. on June 1, 2023. The record date for the meeting was April 4, 2023.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on three proposals, all of which were approved by a majority of votes cast. A total of 20,201,234.71 shares were present in person or by proxy out of 22,142,776 shares entitled to vote.
- Proposal 1 (Election of Directors): Bridget A. Ross and John A. Roush were elected as Class II directors for three-year terms.
- Proposal 2 (Executive Compensation): The advisory vote on named executive officer compensation was approved.
- Proposal 3 (Auditor Ratification): Grant Thornton LLP was ratified as the independent registered public accounting firm for 2023.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Two new directors, Bridget A. Ross and John A. Roush, were elected to the Board.
- Grant Thornton LLP is confirmed as the independent auditor for the fiscal year ending December 31, 2023.
- Stockholders approved the executive compensation advisory vote with significant support (18.6 million shares for vs. 524,894 against).
- Broker non-votes totaled 1,054,259 shares for the director election and executive compensation proposals.